Gérard Soula
Founder chez ADOCIA
Fortune : 10 M $ au 31/03/2024
Profil
Gérard Soula is the founder.
He founded Flamel Technologies SA in 1990, where he held the title of Chairman & Chief Executive Officer from 1990 to 2005.
He also founded Adocia SA in 2005 and currently serves as Chairman.
Dr. Soula's current job is as a Director at Glowbl SAS.
His former positions include being a Director at Veloxis Pharmaceuticals A and Life Cycle Pharma A.
Dr. Soula obtained a doctorate degree from Université d'Aix-Marseille.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ADOCIA SA
7,14% | 31/12/2022 | 1 006 455 ( 7,14% ) | 10 M $ | 31/03/2024 |
Postes actifs de Gérard Soula
Sociétés | Poste | Début |
---|---|---|
ADOCIA | Founder | 16/12/2005 |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Director/Board Member | - |
Anciens postes connus de Gérard Soula
Sociétés | Poste | Fin |
---|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Founder | 01/01/2005 |
Life Cycle Pharma A/S | Director/Board Member | - |
VELOXIS PHARMACEUTICALS A/S | Director/Board Member | - |
Formation de Gérard Soula
Université d'Aix-Marseille | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ADOCIA | Health Technology |
Entreprise privées | 4 |
---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Life Cycle Pharma A/S | |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Technology Services |